For the three months ended December 31, 2024, revenue is expected to be in the range of $642.0 million to $667.0 million. Adjusted EBITDA is expected to be in the range of $22.0 million to $37.0 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVH:
- EVH Earnings this Week: How Will it Perform?
- Evolent Health price target lowered to $33 from $35 at Citi
- Evolent weakness linked to elevated Medicaid MLRs at peers, says Stephens
- Mobileye downgraded, Affirm upgraded: Wall Street’s top analyst calls
- Evolent Health initiated with an Overweight at KeyBanc